learn Osteopontin
signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss
Search
forResearch
5 / 729 results
research You Need a Makeover!: The Social Construction of Female Body Image in A Makeover Story, What Not to Wear, and Extreme Makeover
Makeover TV shows promote unrealistic beauty standards and pressure women to conform to societal ideals.
research A Profile of Advertising in China’s Socialist-Market Economy
Advertising in China shifted towards entertainment, favored local brands, and played a significant role in the country's move to a consumer economy.
research A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.
research How to Speak Postmodern: Medicine, Illness, and Cultural Change
The document suggests medicine should integrate biological and cultural factors and focus on holistic, equitable care.
research Medicalization, Pharmaceutical Promotion, and the Internet: A Critical Multimodal Discourse Analysis of Hair Loss Websites
Commercial hair loss websites promote Propecia by making men feel insecure about baldness and suggesting it's a medical issue needing treatment.
Community Join
5 / 50 resultscommunity Shrooms have done more for my hair loss than all of my hair supplements/medications combined.
Finding acceptance of hair loss through psychedelics, and the potential benefits of shrooms. Discussions include sharing experiences with minoxidil, finasteride, nutrafol, laser therapy, micro needling, as well as mental health concerns such as depression, suicidal thoughts, and self-esteem.
community Nicotinamide Riboside Experience
Nicotinamide Riboside (NR) significantly reduced hair loss for the user. They found science.bio's NR to be effective, unlike other brands.
community Hair Growth Caps and Helmets Research
Hair growth caps and helmets using low-level laser therapy (LLLT) show potential for treating androgenetic alopecia, but more research is needed. Users often combine these devices with treatments like minoxidil and finasteride for better results.
community Korea launches 1st OTC hair loss drug
Korea launched its first OTC oral hair loss drug, dexpanthenol B5. Users discuss its anti-oxidative and anti-inflammatory effects but note a lack of efficacy studies.
community The expected timeline for PP405 - Next update at AAD Annual Meeting in March 2026 ?
A new hair loss treatment, PP405, showed promising Phase 2a results with 31% of patients experiencing over 20% hair density increase without systemic absorption, avoiding hormonal side effects. The treatment is expected to be expensive, with Phase 3 trials starting mid-2026, and there is skepticism about the data's strength.